Niagen Bioscience, Inc.
NAGE· Nasdaq
Filed Mar 16, 2011 · 10-K · 74 days after period end · 0001193125-11-067918
derived · Computed from the longer spans the company filed.
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jan 1, 2011 · filed Mar 16, 2011 · 74 d after period end
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR